Literature DB >> 35505248

Longitudinal multi-omics analyses link gut microbiome dysbiosis with recurrent urinary tract infections in women.

Colin J Worby1, Henry L Schreiber2,3,4, Timothy J Straub1, Lucas R van Dijk1,5, Ryan A Bronson1, Benjamin S Olson2,3, Jerome S Pinkner2, Chloe L P Obernuefemann2, Vanessa L Muñoz2, Alexandra E Paharik2, Philippe N Azimzadeh2, Bruce J Walker6, Christopher A Desjardins1, Wen-Chi Chou1, Karla Bergeron7, Sinéad B Chapman1, Aleksandra Klim7, Abigail L Manson1, Thomas J Hannan8, Thomas M Hooton9, Andrew L Kau3,10, H Henry Lai7,11, Karen W Dodson2,3, Scott J Hultgren12,13, Ashlee M Earl14.   

Abstract

Recurrent urinary tract infections (rUTIs) are a major health burden worldwide, with history of infection being a significant risk factor. While the gut is a known reservoir for uropathogenic bacteria, the role of the microbiota in rUTI remains unclear. We conducted a year-long study of women with (n = 15) and without (n = 16) history of rUTI, from whom we collected urine, blood and monthly faecal samples for metagenomic and transcriptomic interrogation. During the study 24 UTIs were reported, with additional samples collected during and after infection. The gut microbiome of individuals with a history of rUTI was significantly depleted in microbial richness and butyrate-producing bacteria compared with controls, reminiscent of other inflammatory conditions. However, Escherichia coli gut and bladder populations were comparable between cohorts in both relative abundance and phylogroup. Transcriptional analysis of peripheral blood mononuclear cells revealed expression profiles indicative of differential systemic immunity between cohorts. Altogether, these results suggest that rUTI susceptibility is in part mediated through the gut-bladder axis, comprising gut dysbiosis and differential immune response to bacterial bladder colonization, manifesting in symptoms.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Year:  2022        PMID: 35505248      PMCID: PMC9136705          DOI: 10.1038/s41564-022-01107-x

Source DB:  PubMed          Journal:  Nat Microbiol        ISSN: 2058-5276            Impact factor:   30.964


  58 in total

1.  Genomic identity of pyelonephritogenic Escherichia coli isolated from blood, urine and faeces of children with urosepsis.

Authors:  Maria E Jantunen; H Saxén; Susanna Lukinmaa; Marja Ala-Houhala; Anja Siitonen
Journal:  J Med Microbiol       Date:  2001-07       Impact factor: 2.472

Review 2.  Urinary tract infections: epidemiology, mechanisms of infection and treatment options.

Authors:  Ana L Flores-Mireles; Jennifer N Walker; Michael Caparon; Scott J Hultgren
Journal:  Nat Rev Microbiol       Date:  2015-04-08       Impact factor: 60.633

3.  Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection Reduces Recurrent Urinary Tract Infection Frequency.

Authors:  Raseen Tariq; Darrell S Pardi; Pritish K Tosh; Randall C Walker; Raymund R Razonable; Sahil Khanna
Journal:  Clin Infect Dis       Date:  2017-10-30       Impact factor: 9.079

4.  A prospective study of risk factors for symptomatic urinary tract infection in young women.

Authors:  T M Hooton; D Scholes; J P Hughes; C Winter; P L Roberts; A E Stapleton; A Stergachis; W E Stamm
Journal:  N Engl J Med       Date:  1996-08-15       Impact factor: 91.245

5.  Genetic evidence supporting the fecal-perineal-urethral hypothesis in cystitis caused by Escherichia coli.

Authors:  S Yamamoto; T Tsukamoto; A Terai; H Kurazono; Y Takeda; O Yoshida
Journal:  J Urol       Date:  1997-03       Impact factor: 7.450

6.  Gut commensal microbiota and decreased risk for Enterobacteriaceae bacteriuria and urinary tract infection.

Authors:  Matthew Magruder; Emmanuel Edusei; Lisa Zhang; Shady Albakry; Michael J Satlin; Lars F Westblade; Line Malha; Christina Sze; Michelle Lubetzky; Darshana M Dadhania; John R Lee
Journal:  Gut Microbes       Date:  2020-11-09

7.  Faecal Escherichia coli from patients with E. coli urinary tract infection and healthy controls who have never had a urinary tract infection.

Authors:  Karen L Nielsen; Pia Dynesen; Preben Larsen; Niels Frimodt-Møller
Journal:  J Med Microbiol       Date:  2014-01-25       Impact factor: 2.472

8.  Intestinal microbiome as a risk factor for urinary tract infections in children.

Authors:  Niko Paalanne; Aleksi Husso; Jarmo Salo; Oskari Pieviläinen; Mysore V Tejesvi; Pirjo Koivusaari; Anna Maria Pirttilä; Tytti Pokka; Sampo Mattila; Juha Jyrkäs; Ari Turpeinen; Matti Uhari; Marjo Renko; Terhi Tapiainen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-07-13       Impact factor: 3.267

9.  Fecal Microbiota Transplant for Refractory Clostridium difficile Infection Interrupts 25-Year History of Recurrent Urinary Tract Infections.

Authors:  Tiffany Wang; Colleen S Kraft; Michael H Woodworth; Tanvi Dhere; Molly E Eaton
Journal:  Open Forum Infect Dis       Date:  2018-01-15       Impact factor: 3.835

10.  Gut uropathogen abundance is a risk factor for development of bacteriuria and urinary tract infection.

Authors:  Matthew Magruder; Adam N Sholi; Catherine Gong; Lisa Zhang; Emmanuel Edusei; Jennifer Huang; Shady Albakry; Michael J Satlin; Lars F Westblade; Carl Crawford; Darshana M Dadhania; Michelle Lubetzky; Ying Taur; Eric Littman; Lilan Ling; Philip Burnham; Iwijn De Vlaminck; Eric Pamer; Manikkam Suthanthiran; John Richard Lee
Journal:  Nat Commun       Date:  2019-12-04       Impact factor: 14.919

View more
  6 in total

1.  Gut-bladder axis enters the stage: Implication for recurrent urinary tract infections.

Authors:  Arnold M Salazar; Michael L Neugent; Nicole J De Nisco; Indira U Mysorekar
Journal:  Cell Host Microbe       Date:  2022-08-10       Impact factor: 31.316

Review 2.  The impact of biological sex on diseases of the urinary tract.

Authors:  Léa Deltourbe; Livia Lacerda Mariano; Teri N Hreha; David A Hunstad; Molly A Ingersoll
Journal:  Mucosal Immunol       Date:  2022-07-22       Impact factor: 8.701

3.  Transmission of Antibiotic-Susceptible Escherichia coli Causing Urinary Tract Infections in a Fecal Microbiota Transplantation Recipient: Consequences for Donor Screening?

Authors:  Karuna E W Vendrik; Tim G J de Meij; Arend Bökenkamp; Rogier E Ooijevaar; Bas Groenewegen; Antoni P A Hendrickx; Elisabeth M Terveer; Ed J Kuijper; Joffrey van Prehn
Journal:  Open Forum Infect Dis       Date:  2022-06-29       Impact factor: 4.423

4.  Integrative Multi-Omics Analysis for the Determination of Non-Muscle Invasive vs. Muscle Invasive Bladder Cancer: A Pilot Study.

Authors:  Evan Yi-Wen Yu; Hao Zhang; Yuanqing Fu; Ya-Ting Chen; Qiu-Yi Tang; Yu-Xiang Liu; Yan-Xi Zhang; Shi-Zhi Wang; Anke Wesselius; Wen-Chao Li; Maurice P Zeegers; Bin Xu
Journal:  Curr Oncol       Date:  2022-07-31       Impact factor: 3.109

5.  An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with In Vivo Efficacy against Drug-Resistant Gram-Negative Infections.

Authors:  Erica N Parker; Brett N Cain; Behnoush Hajian; Rebecca J Ulrich; Emily J Geddes; Sulyman Barkho; Hyang Yeon Lee; John D Williams; Malik Raynor; Diana Caridha; Angela Zaino; Mrinal Shekhar; Kristen A Muñoz; Kara M Rzasa; Emily R Temple; Diana Hunt; Xiannu Jin; Chau Vuong; Kristina Pannone; Aya M Kelly; Michael P Mulligan; Katie K Lee; Gee W Lau; Deborah T Hung; Paul J Hergenrother
Journal:  ACS Cent Sci       Date:  2022-08-10       Impact factor: 18.728

Review 6.  Gut Microbiota in Nutrition and Health with a Special Focus on Specific Bacterial Clusters.

Authors:  Lucas R F Bresser; Marcus C de Goffau; Evgeni Levin; Max Nieuwdorp
Journal:  Cells       Date:  2022-09-30       Impact factor: 7.666

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.